PLUS1
5.97
-0.06 (-1.0%)
-0.06 (-1.0%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eyenovia Inc | EYEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.06 | -1.0% | 5.97 | 14:25:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.09 | 5.84 | 6.69 | 6.03 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 5.94 | 6.00 | 0.06 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 876 | 188,561 | $ 6.10 | $ 1,150,463 | 292,362 | 1.11 - 7.72 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:25:52 | 200 | $ 5.97 | USD |
Eyenovia Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 148.56M | 24.88M | 18.06M | $ - | $ - | -1.51 | -6.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -871.93k | 9.40% |
Eyenovia News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/19/2021 | 16:41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 1/06/2021 | 17:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/29/2020 | 07:30 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 12/18/2020 | 07:32 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/24/2020 | 16:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/24/2020 | 16:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/13/2020 | 09:58 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EYEN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.04 | 7.24 | 5.84 | 6.42 | 90,298 | -1.07 | -15.2% |
| 1 Month | 6.26 | 7.72 | 5.84 | 6.73 | 128,695 | -0.29 | -4.63% |
| 3 Months | 3.67 | 7.72 | 3.6112 | 5.89 | 226,348 | 2.30 | 62.67% |
| 6 Months | 3.65 | 7.72 | 2.90 | 4.69 | 197,498 | 2.32 | 63.56% |
| 1 Year | 4.125 | 7.72 | 1.11 | 4.70 | 403,138 | 1.85 | 44.73% |
| 3 Years | 9.49 | 9.611 | 1.11 | 4.53 | 190,810 | -3.52 | -37.09% |
| 5 Years | 10.00 | 10.74 | 1.11 | 4.60 | 188,075 | -4.03 | -40.3% |
Eyenovia Description
| Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia. |
